Benjamin Oshrine
Overview
Explore the profile of Benjamin Oshrine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fierro-Pineda J, Tsai H, Blackford A, Cluster A, Caywood E, Dalal J, et al.
Blood Adv
. 2023 May;
7(18):5639-5648.
PMID: 37257193
Promising results have been reported for adult patients with high-risk hematologic malignancies undergoing haploidentical bone marrow transplant (haploBMT) with posttransplant cyclophosphamide (PTCy). To our knowledge, we report results from the...
2.
Brown A, Carapellucci J, Oshrine B, Gomez A, Meoded A, Asante-Korang A
Clin Transplant
. 2023 May;
37(9):e15015.
PMID: 37237443
Background: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of pediatric heart transplant (PHTx). 18F-FDG PET/CT has been used to differentiate early lympho-proliferation from more advanced PTLD. We report our...
3.
Carpenter P, Kang H, Yoo K, Zecca M, Cho B, Lucchini G, et al.
Transplant Cell Ther
. 2022 Aug;
28(11):771.e1-771.e10.
PMID: 36044977
Chronic graft-versus-host disease (cGVHD) is a potentially life-threatening complication of allogeneic hematopoietic stem cell transplantation. Clinical data surrounding cGVHD therapies in younger children are limited and critically needed. Primary endpoints...
4.
McNerney K, Oranges K, Seif A, Oshrine B, Ky B, Lin K, et al.
J Pediatr Hematol Oncol
. 2022 Feb;
44(2):e507-e511.
PMID: 35200224
Gemtuzumab ozogamicin (GO) is an anti-CD33 antibody-tumor antibiotic conjugate with proven efficacy in pediatric and adult patients with CD33+ acute myeloid leukemia. Adverse effects commonly associated with GO include hyperbilirubinemia,...
5.
Oshrine B, Innamarato P, Branthoover H, Nagle L, Verdugo P, Pilon-Thomas S, et al.
Transplant Cell Ther
. 2022 Jan;
28(4):203.e1-203.e7.
PMID: 34995816
Allogeneic hematopoietic cell transplantation (alloHCT) using haploidentical donors (haploHCT) with post-transplantation cyclophosphamide (PTCy) for augmented graft-versus-host disease (GVHD) prophylaxis has emerged as a robust platform to expand donor options with...
6.
Kidder M, Phen C, Brown J, Kimsey K, Oshrine B, Ghazarian S, et al.
Pediatr Gastroenterol Hepatol Nutr
. 2021 Nov;
24(6):546-554.
PMID: 34796099
Purpose: Malnutrition is a significant issue for pediatric patients with cancer. We sought to evaluate the effectiveness and complication rate of percutaneous endoscopic gastrostomy (PEG) placement in pediatric oncology patients....
7.
Horn B, Lamba N, Chellapandian D, Sunkersett G, Silva J, Ziga E, et al.
Pediatr Blood Cancer
. 2021 Jun;
68(10):e29180.
PMID: 34121322
Background: Previous studies have explored posthematopoietic cell transplant (HCT) outcomes by race in adults; however, pediatric data addressing this topic are scarce. Procedure: This retrospective registry study included 238 White...
8.
Durno C, Ercan A, Bianchi V, Edwards M, Aronson M, Galati M, et al.
J Clin Oncol
. 2021 May;
39(25):2779-2790.
PMID: 33945292
Purpose: Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors. We designed a surveillance protocol for early tumor detection...
9.
Kalin J, Nguyen A, Oshrine B
Pediatr Blood Cancer
. 2021 Jan;
68(4):e28902.
PMID: 33484054
Background: Bone marrow graft cell content impacts engraftment potential after allogeneic hematopoietic cell transplantation (alloHCT). Surrogates, such as intraoperative total nucleated cell count (ioTNC), are of unclear utility in predicting...
10.
Hecht A, Meyer J, Behnert A, Wong E, Chehab F, Olshen A, et al.
Haematologica
. 2020 Dec;
107(1):178-186.
PMID: 33375775
Mutations in the gene CBL were first identified in adults with various myeloid malignancies. Some patients with juvenile myelomonocytic leukemia (JMML) were also noted to harbor mutations in CBL, but...